Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

Posters

At TwinStrand we put science first in everything we do. We routinely present at academic conferences to share our own discoveries as well as those made with our many collaborators across the scientific spectrum.

An Updated Duplex Sequencing Mutagenesis Assay Accurately and Reproducibly Detects Mutation Frequencies Below One-In-Ten-Million

An AML targeted Duplex Sequencing assay can detect Measurable Residual Disease (MRD) at a sensitivity better than 0.01% Variant Allele Frequency

Novel DNA Standards for Assessing Technical Sensitivity and Reproducibility Duplex Sequencing Mutagenesis Assays

Duplex Sequencing for mutagenesis testing in wild type rodents and a common human cell line

Ultra-Sensitive Duplex Sequencing for Quantifying Multi-Individual Cell Therapy Sub-Population Fractions

Duplex Sequencing reveals ubiquitous clonal hematopoiesis and complex donor-recipient clonal dynamics following hematopoietic stem cell transplant

Longitudinal monitoring of pediatric acute myeloid leukemia using duplex sequencing of patient-specific panels reveals ultra-low frequency MRD that marks persistent carcinogenesis and complex clonal evolution

Ultra-Sensitive Duplex Sequencing for Tracking of Allogeneic Cell Therapies

Detection of Ultra-rare Mutations in vivo Establish biomarkers of Endogenous and Environmental Exposure

Duplex Sequencing Detects Rare Subclonal Variants that Mark Early Carcinogenesis and Preneoplastic Clonal Evolution

Duplex Sequencing for MRD Detection in Acute Myeloid Leukemia

Super CHIP: Duplex Sequencing Reveals Clonal Dynamics in Blood that are Magnitudes more Complex than Previously Recognized

Non-invasive Detection of Aristolochic Acid Exposure Using Ultra-Sensitive Duplex Sequencing

SOT-2024-An-Updated-Duplex-Sequencing-Mutagenesis-Assay-Accurately-and-Reproducibly-Detects-Mutation-Frequencies-Below-One-In-Ten-Million

Redefining “Gold Standard” Ultra-Sensitive Characterization of Commercial DNA Standards with Duplex Sequencing